Eloxx Pharmaceuticals (ELOX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Eloxx Pharmaceuticals (ELOX) is Neutral.

The composite score behind that read is +0.01, weighing +0.36 of bullish evidence against -0.53 bearish.

Eloxx Pharmaceuticals last closed at $13.74, -9.49% on the session.

Against the IVW growth benchmark the position is -10.29% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

10 graded predictions for ELOX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Eloxx Pharmaceuticals is classified under Health Care / Pharmaceuticals, with a market capitalisation of $61.27M.

StockMap tracks Eloxx Pharmaceuticals as the 110th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Eloxx Pharmaceuticals ranks 53rd of 151 in the group, against a group median of -0.08.